CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing advanced nanometric drug delivery systems that enhance targeted therapy for cancer. By creating thermo-responsive metal/polymer hybrid nanoparticles, the aim is to improve drug delivery efficiency and specificity towards malignant cells, potentially transforming treatment approaches i…
Current nanometric drug delivery systems have enormous potential to shift clinical practice in diseases that require targeted or site-specific therapy.
New tools to fabricating multi-functional drug delivery systems can potentiate drug-carrier activity and offer the necessary shift from inert carriers to active drug carriers that can maximize drug activity in the desired tissue.
This is particularly crucial in cancer, where chemotherapy drugs have broad spectrum non-specific activities.
Based o…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
